The Effects of DPP-4 Inhibitors, GLP-1RAs, and SGLT-2/1 Inhibitors on Heart Failure Outcomes in Diabetic Patients With and Without Heart Failure History: Insights From CVOTs and Drug Mechanism
Overview of clinical trials In the wake of phase I and phase II trials promising results, the clinical trials of phase III (Table 1) were designed to evaluate the safety and efficacy of tirzepatide for improving glycemic control in patients with T2DM in eight published SURPASS trials (SURPASS 1-5, SURPASS J-mono, and SURPASS J-combo) [8-10,25-28] and for treating obesity in the SURMOUNT trial (SURMOUNT-1) [29]
Is GLP-1 safe for everyone
In contrast to other neurodegenerative diseases such as Alzheimers and Huntingtons diseases (AD and HD), many of the characteristics of PD can be reproduced in vivo by the use of specific neurotoxins
Here are 7 evidence-based tips for researchers looking to design a weight loss intervention: Subjects should prioritize low-calorie foods, since maintaining a calorie deficit is essential to successful weight loss interventions
Al elegir, combina ttulos con distinta volatilidad para equilibrar rachas y ajustar las expectativas a tu estilo
